Stroke Prevention in Nonvalvular Atrial Fibrillation

被引：0
|
作者：
Ganjehei, Leila [1 ]
Massumi, Ali [1 ]
Razavi, Mehdi [1 ]
Rasekh, Abdi [1 ]
机构：
[1] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiol, Houston, TX 77030 USA
来源：
TEXAS HEART INSTITUTE JOURNAL | 2011年 / 38卷 / 04期
关键词：
APPENDAGE OCCLUSION; WARFARIN THERAPY; OBLITERATION; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：350 / 352
页数：3
相关论文
共 50 条
  • [41] AHA/ASA Publish Advisory on Oral Antithrombotics for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Devitt, Michael
    AMERICAN FAMILY PHYSICIAN, 2013, 87 (10) : 732 - 733
  • [42] Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation patient considerations
    Ahrens, Ingo
    Bode, Christoph
    JOURNAL OF BLOOD MEDICINE, 2014, 5 : 25 - 30
  • [43] Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
    Lin, Yi-Pin
    Tan, Teng-Yeow
    MEDICINE, 2015, 94 (38)
  • [44] Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation
    Kimura, Teruo
    Tucker, Adam
    Nakagaki, Atsushi
    Sugimura, Toshihide
    Fukuda, Shin
    Katsuno, Makoto
    Fujita, Tsutomu
    Izumi, Naoto
    Suzuki, Nozomi
    Sako, Kazuhiro
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (08):
  • [45] Apixaban: A New Factor Xa Inhibitor for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
    Lam, Sum
    CARDIOLOGY IN REVIEW, 2013, 21 (04) : 207 - 212
  • [46] Warfarin vs aspirin for prevention of stroke in nonvalvular atrial fibrillation: Meta-analysis
    Benavente, O
    Hart, RG
    STROKE, 1999, 30 (01) : 241 - 241
  • [47] Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation
    Helms T.M.
    Silber S.
    Schäfer A.
    Masuhr F.
    Palm F.
    Darius H.
    Schrör K.
    Bänsch D.
    Bramlage P.
    Hankowitz J.
    Karle C.A.
    Stargardt T.
    Weil J.
    Geller J.C.
    Herzschrittmachertherapie + Elektrophysiologie, 2016, 27 (3) : 295 - 306
  • [48] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Lip, Gregory Y. H.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Chalkiadaki, Corina
    Liu, Xianchen
    Kuznik, Andreas
    Lawrence, Jack
    Dorian, Paul
    CLINICAL THERAPEUTICS, 2015, 37 (11) : 2476 - 2488
  • [49] Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study
    Yasaka, Masahiro
    Umeyama, Michiaki
    Kataoka, Hirohide
    Inoue, Hiroshi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (09):
  • [50] Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses
    Kilickap, Mustafa
    Bosch, Jackie
    Eikelboom, John W.
    Hart, Robert G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (09) : 1108 - 1116
12345